Hygea VCT plc : Interim Management Statement

HYGEA VCT PLC

INTERIM MANAGEMENT STATEMENT

Hygea vct plc ('the Company') presents its interim management statement for the period from 1 January 2014 to 7 May 2014. This constitutes the Company's first interim management statement for the financial year ending 31 December 2014, as required by the UK Listing Authority's Disclosure and Transparency Rule 4.3. This statement has been prepared solely to provide additional information in order to meet the requirements of the Disclosure and Transparency Rules and should not be relied on by shareholders, or any other party, for any other purpose.

The unaudited net asset value per ordinary share and the number of shares in issue at 31 March 2014 were 97.7p and 8,115,376 respectively (31 December 2013: 96.5p and 8,115,376 respectively).  There were no shares held in Treasury at either date.

No shares have been issued or repurchased during the period.

At 31 March 2014, the Company's assets included its portfolio of unlisted assets along with £60,877 in cash and £5,687,078 in AIM traded shares valued at bid price. During the period the Company sold 195,000 shares in Omega Diagnostics Group PLC at an average price of 31.5p per share following the rise in the price after the announcement of positive results.

During the three months ended 31 March 2014, as previously announced, the Company made a further investment of £50,000 into what was Eykona Technologies Limited, which has now been restructured to become Fuel 3D Technologies Limited and a further £9,900 into Microarray Limited, the successor company to Archimed LLP. Since the 31 March 2014, the Company has invested a further £11,000 into Axon Limited.

The Directors are not aware of any other events which have taken place between 31 March 2014 and the date of publication of this statement, which have had a material effect on the financial position of the Company.

Enquiries:
James Otter, Hygea vct plc on 01730 829877 or [e-mail]
Charles Breese, Hygea vct plc on 01280 703482 or [e-mail]
Roland Cornish, Beaumont Cornish Limited on 020 7628 3396

website: www.hygeavct.com

---

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Hygea VCT plc via Globenewswire

HUG#1783357